nodes	percent_of_prediction	percent_of_DWPC	metapath
Clavulanate—Pseudomembranous colitis—Ritonavir—acquired immunodeficiency syndrome	0.0219	0.0219	CcSEcCtD
Clavulanate—Jaundice cholestatic—Ritonavir—acquired immunodeficiency syndrome	0.0124	0.0124	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Amprenavir—acquired immunodeficiency syndrome	0.0113	0.0113	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Nevirapine—acquired immunodeficiency syndrome	0.0109	0.0109	CcSEcCtD
Clavulanate—Swelling—Indinavir—acquired immunodeficiency syndrome	0.0107	0.0107	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Abacavir—acquired immunodeficiency syndrome	0.0104	0.0104	CcSEcCtD
Clavulanate—Eosinophilia—Nevirapine—acquired immunodeficiency syndrome	0.0104	0.0104	CcSEcCtD
Clavulanate—Thrombophlebitis—Efavirenz—acquired immunodeficiency syndrome	0.0103	0.0103	CcSEcCtD
Clavulanate—Swelling—Delavirdine—acquired immunodeficiency syndrome	0.00972	0.00972	CcSEcCtD
Clavulanate—Erythema multiforme—Amprenavir—acquired immunodeficiency syndrome	0.0097	0.0097	CcSEcCtD
Clavulanate—Hepatitis—Didanosine—acquired immunodeficiency syndrome	0.00935	0.00935	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Nevirapine—acquired immunodeficiency syndrome	0.00928	0.00928	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Zidovudine—acquired immunodeficiency syndrome	0.00918	0.00918	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Abacavir—acquired immunodeficiency syndrome	0.00883	0.00883	CcSEcCtD
Clavulanate—Thrombophlebitis—Saquinavir—acquired immunodeficiency syndrome	0.00881	0.00881	CcSEcCtD
Clavulanate—Hepatitis—Nevirapine—acquired immunodeficiency syndrome	0.00841	0.00841	CcSEcCtD
Clavulanate—Haemoglobin—Nelfinavir—acquired immunodeficiency syndrome	0.00818	0.00818	CcSEcCtD
Clavulanate—Hypokalaemia—Efavirenz—acquired immunodeficiency syndrome	0.00815	0.00815	CcSEcCtD
Clavulanate—Haemorrhage—Nelfinavir—acquired immunodeficiency syndrome	0.00814	0.00814	CcSEcCtD
Clavulanate—Hepatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00814	0.00814	CcSEcCtD
Clavulanate—Hepatitis—Stavudine—acquired immunodeficiency syndrome	0.00812	0.00812	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Efavirenz—acquired immunodeficiency syndrome	0.00807	0.00807	CcSEcCtD
Clavulanate—Hepatitis—Abacavir—acquired immunodeficiency syndrome	0.008	0.008	CcSEcCtD
Clavulanate—Erythema multiforme—Nevirapine—acquired immunodeficiency syndrome	0.00795	0.00795	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Zidovudine—acquired immunodeficiency syndrome	0.00779	0.00779	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Delavirdine—acquired immunodeficiency syndrome	0.00772	0.00772	CcSEcCtD
Clavulanate—Erythema multiforme—Nelfinavir—acquired immunodeficiency syndrome	0.0077	0.0077	CcSEcCtD
Clavulanate—Erythema multiforme—Abacavir—acquired immunodeficiency syndrome	0.00756	0.00756	CcSEcCtD
Clavulanate—Eosinophilia—Delavirdine—acquired immunodeficiency syndrome	0.00734	0.00734	CcSEcCtD
Clavulanate—Leukopenia—Didanosine—acquired immunodeficiency syndrome	0.00728	0.00728	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Indinavir—acquired immunodeficiency syndrome	0.00724	0.00724	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Ritonavir—acquired immunodeficiency syndrome	0.00714	0.00714	CcSEcCtD
Clavulanate—Hepatitis—Zidovudine—acquired immunodeficiency syndrome	0.00705	0.00705	CcSEcCtD
Clavulanate—Hypokalaemia—Saquinavir—acquired immunodeficiency syndrome	0.00694	0.00694	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Efavirenz—acquired immunodeficiency syndrome	0.00685	0.00685	CcSEcCtD
Clavulanate—Erythema multiforme—Zidovudine—acquired immunodeficiency syndrome	0.00667	0.00667	CcSEcCtD
Clavulanate—Anaphylactic shock—Didanosine—acquired immunodeficiency syndrome	0.00664	0.00664	CcSEcCtD
Clavulanate—Haemoglobin—Indinavir—acquired immunodeficiency syndrome	0.00659	0.00659	CcSEcCtD
Clavulanate—Hepatitis—Indinavir—acquired immunodeficiency syndrome	0.00656	0.00656	CcSEcCtD
Clavulanate—Haemorrhage—Indinavir—acquired immunodeficiency syndrome	0.00656	0.00656	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Delavirdine—acquired immunodeficiency syndrome	0.00655	0.00655	CcSEcCtD
Clavulanate—Thrombocytopenia—Didanosine—acquired immunodeficiency syndrome	0.0065	0.0065	CcSEcCtD
Clavulanate—Leukopenia—Nelfinavir—acquired immunodeficiency syndrome	0.00634	0.00634	CcSEcCtD
Clavulanate—Leukopenia—Stavudine—acquired immunodeficiency syndrome	0.00632	0.00632	CcSEcCtD
Clavulanate—Leukopenia—Abacavir—acquired immunodeficiency syndrome	0.00623	0.00623	CcSEcCtD
Clavulanate—Erythema multiforme—Indinavir—acquired immunodeficiency syndrome	0.0062	0.0062	CcSEcCtD
Clavulanate—Hepatitis—Efavirenz—acquired immunodeficiency syndrome	0.0062	0.0062	CcSEcCtD
Clavulanate—Convulsion—Nelfinavir—acquired immunodeficiency syndrome	0.00614	0.00614	CcSEcCtD
Clavulanate—Convulsion—Abacavir—acquired immunodeficiency syndrome	0.00603	0.00603	CcSEcCtD
Clavulanate—Anaphylactic shock—Nevirapine—acquired immunodeficiency syndrome	0.00597	0.00597	CcSEcCtD
Clavulanate—Hepatitis—Delavirdine—acquired immunodeficiency syndrome	0.00593	0.00593	CcSEcCtD
Clavulanate—Erythema multiforme—Efavirenz—acquired immunodeficiency syndrome	0.00586	0.00586	CcSEcCtD
Clavulanate—Thrombocytopenia—Nevirapine—acquired immunodeficiency syndrome	0.00585	0.00585	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Saquinavir—acquired immunodeficiency syndrome	0.00583	0.00583	CcSEcCtD
Clavulanate—Anaphylactic shock—Abacavir—acquired immunodeficiency syndrome	0.00568	0.00568	CcSEcCtD
Clavulanate—Pain—Didanosine—acquired immunodeficiency syndrome	0.00568	0.00568	CcSEcCtD
Clavulanate—Thrombocytopenia—Nelfinavir—acquired immunodeficiency syndrome	0.00566	0.00566	CcSEcCtD
Clavulanate—Thrombocytopenia—Stavudine—acquired immunodeficiency syndrome	0.00565	0.00565	CcSEcCtD
Clavulanate—Erythema multiforme—Delavirdine—acquired immunodeficiency syndrome	0.00561	0.00561	CcSEcCtD
Clavulanate—Thrombocytopenia—Abacavir—acquired immunodeficiency syndrome	0.00556	0.00556	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Lamivudine—acquired immunodeficiency syndrome	0.00556	0.00556	CcSEcCtD
Clavulanate—Haemoglobin—Ritonavir—acquired immunodeficiency syndrome	0.00551	0.00551	CcSEcCtD
Clavulanate—Leukopenia—Zidovudine—acquired immunodeficiency syndrome	0.0055	0.0055	CcSEcCtD
Clavulanate—Haemorrhage—Ritonavir—acquired immunodeficiency syndrome	0.00548	0.00548	CcSEcCtD
Clavulanate—Hepatitis—Ritonavir—acquired immunodeficiency syndrome	0.00548	0.00548	CcSEcCtD
Clavulanate—Convulsion—Zidovudine—acquired immunodeficiency syndrome	0.00532	0.00532	CcSEcCtD
Clavulanate—Haemoglobin—Saquinavir—acquired immunodeficiency syndrome	0.00531	0.00531	CcSEcCtD
Clavulanate—Haemorrhage—Saquinavir—acquired immunodeficiency syndrome	0.00528	0.00528	CcSEcCtD
Clavulanate—Hepatitis—Saquinavir—acquired immunodeficiency syndrome	0.00528	0.00528	CcSEcCtD
Clavulanate—Erythema multiforme—Ritonavir—acquired immunodeficiency syndrome	0.00519	0.00519	CcSEcCtD
Clavulanate—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.00515	0.00515	CcSEcCtD
Clavulanate—Pain—Nevirapine—acquired immunodeficiency syndrome	0.00511	0.00511	CcSEcCtD
Clavulanate—Hepatitis—Lamivudine—acquired immunodeficiency syndrome	0.00504	0.00504	CcSEcCtD
Clavulanate—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.00501	0.00501	CcSEcCtD
Clavulanate—Erythema multiforme—Saquinavir—acquired immunodeficiency syndrome	0.00499	0.00499	CcSEcCtD
Clavulanate—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.00498	0.00498	CcSEcCtD
Clavulanate—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.00495	0.00495	CcSEcCtD
Clavulanate—Pain—Stavudine—acquired immunodeficiency syndrome	0.00493	0.00493	CcSEcCtD
Clavulanate—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.00491	0.00491	CcSEcCtD
Clavulanate—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00489	0.00489	CcSEcCtD
Clavulanate—Pain—Abacavir—acquired immunodeficiency syndrome	0.00486	0.00486	CcSEcCtD
Clavulanate—Erythema multiforme—Lamivudine—acquired immunodeficiency syndrome	0.00476	0.00476	CcSEcCtD
Clavulanate—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.00474	0.00474	CcSEcCtD
Clavulanate—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.0047	0.0047	CcSEcCtD
Clavulanate—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.00467	0.00467	CcSEcCtD
Clavulanate—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.00466	0.00466	CcSEcCtD
Clavulanate—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00463	0.00463	CcSEcCtD
Clavulanate—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.00462	0.00462	CcSEcCtD
Clavulanate—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.00459	0.00459	CcSEcCtD
Clavulanate—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00459	0.00459	CcSEcCtD
Clavulanate—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00459	0.00459	CcSEcCtD
Clavulanate—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00458	0.00458	CcSEcCtD
Clavulanate—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.00456	0.00456	CcSEcCtD
Clavulanate—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00454	0.00454	CcSEcCtD
Clavulanate—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.00451	0.00451	CcSEcCtD
Clavulanate—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.0044	0.0044	CcSEcCtD
Clavulanate—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00433	0.00433	CcSEcCtD
Clavulanate—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.00431	0.00431	CcSEcCtD
Clavulanate—Pain—Zidovudine—acquired immunodeficiency syndrome	0.00429	0.00429	CcSEcCtD
Clavulanate—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.00427	0.00427	CcSEcCtD
Clavulanate—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00426	0.00426	CcSEcCtD
Clavulanate—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00425	0.00425	CcSEcCtD
Clavulanate—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00422	0.00422	CcSEcCtD
Clavulanate—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00422	0.00422	CcSEcCtD
Clavulanate—Rash—Didanosine—acquired immunodeficiency syndrome	0.00419	0.00419	CcSEcCtD
Clavulanate—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00418	0.00418	CcSEcCtD
Clavulanate—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00418	0.00418	CcSEcCtD
Clavulanate—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.00414	0.00414	CcSEcCtD
Clavulanate—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.00413	0.00413	CcSEcCtD
Clavulanate—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.00411	0.00411	CcSEcCtD
Clavulanate—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00409	0.00409	CcSEcCtD
Clavulanate—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00409	0.00409	CcSEcCtD
Clavulanate—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00408	0.00408	CcSEcCtD
Clavulanate—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00402	0.00402	CcSEcCtD
Clavulanate—Pain—Indinavir—acquired immunodeficiency syndrome	0.00399	0.00399	CcSEcCtD
Clavulanate—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00398	0.00398	CcSEcCtD
Clavulanate—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.00398	0.00398	CcSEcCtD
Clavulanate—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00396	0.00396	CcSEcCtD
Clavulanate—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00395	0.00395	CcSEcCtD
Clavulanate—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00394	0.00394	CcSEcCtD
Clavulanate—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.00392	0.00392	CcSEcCtD
Clavulanate—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00389	0.00389	CcSEcCtD
Clavulanate—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.00381	0.00381	CcSEcCtD
Clavulanate—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.0038	0.0038	CcSEcCtD
Clavulanate—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.0038	0.0038	CcSEcCtD
Clavulanate—Pain—Efavirenz—acquired immunodeficiency syndrome	0.00377	0.00377	CcSEcCtD
Clavulanate—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00377	0.00377	CcSEcCtD
Clavulanate—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00376	0.00376	CcSEcCtD
Clavulanate—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.0037	0.0037	CcSEcCtD
Clavulanate—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00368	0.00368	CcSEcCtD
Clavulanate—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.00367	0.00367	CcSEcCtD
Clavulanate—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00367	0.00367	CcSEcCtD
Clavulanate—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00365	0.00365	CcSEcCtD
Clavulanate—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00364	0.00364	CcSEcCtD
Clavulanate—Rash—Stavudine—acquired immunodeficiency syndrome	0.00364	0.00364	CcSEcCtD
Clavulanate—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00363	0.00363	CcSEcCtD
Clavulanate—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00361	0.00361	CcSEcCtD
Clavulanate—Pain—Delavirdine—acquired immunodeficiency syndrome	0.0036	0.0036	CcSEcCtD
Clavulanate—Rash—Abacavir—acquired immunodeficiency syndrome	0.00358	0.00358	CcSEcCtD
Clavulanate—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00358	0.00358	CcSEcCtD
Clavulanate—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.00358	0.00358	CcSEcCtD
Clavulanate—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00355	0.00355	CcSEcCtD
Clavulanate—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00355	0.00355	CcSEcCtD
Clavulanate—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.0035	0.0035	CcSEcCtD
Clavulanate—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.0035	0.0035	CcSEcCtD
Clavulanate—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00344	0.00344	CcSEcCtD
Clavulanate—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00343	0.00343	CcSEcCtD
Clavulanate—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00343	0.00343	CcSEcCtD
Clavulanate—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00342	0.00342	CcSEcCtD
Clavulanate—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00337	0.00337	CcSEcCtD
Clavulanate—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00335	0.00335	CcSEcCtD
Clavulanate—Pain—Ritonavir—acquired immunodeficiency syndrome	0.00333	0.00333	CcSEcCtD
Clavulanate—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.0033	0.0033	CcSEcCtD
Clavulanate—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00324	0.00324	CcSEcCtD
Clavulanate—Pain—Saquinavir—acquired immunodeficiency syndrome	0.00321	0.00321	CcSEcCtD
Clavulanate—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00319	0.00319	CcSEcCtD
Clavulanate—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00319	0.00319	CcSEcCtD
Clavulanate—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00316	0.00316	CcSEcCtD
Clavulanate—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00316	0.00316	CcSEcCtD
Clavulanate—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00312	0.00312	CcSEcCtD
Clavulanate—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.0031	0.0031	CcSEcCtD
Clavulanate—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.0031	0.0031	CcSEcCtD
Clavulanate—Pain—Lamivudine—acquired immunodeficiency syndrome	0.00306	0.00306	CcSEcCtD
Clavulanate—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.00301	0.00301	CcSEcCtD
Clavulanate—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00298	0.00298	CcSEcCtD
Clavulanate—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.00298	0.00298	CcSEcCtD
Clavulanate—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00298	0.00298	CcSEcCtD
Clavulanate—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00296	0.00296	CcSEcCtD
Clavulanate—Rash—Indinavir—acquired immunodeficiency syndrome	0.00294	0.00294	CcSEcCtD
Clavulanate—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00294	0.00294	CcSEcCtD
Clavulanate—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00288	0.00288	CcSEcCtD
Clavulanate—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.00287	0.00287	CcSEcCtD
Clavulanate—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.00284	0.00284	CcSEcCtD
Clavulanate—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.0028	0.0028	CcSEcCtD
Clavulanate—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00278	0.00278	CcSEcCtD
Clavulanate—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00277	0.00277	CcSEcCtD
Clavulanate—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00277	0.00277	CcSEcCtD
Clavulanate—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.00276	0.00276	CcSEcCtD
Clavulanate—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.00276	0.00276	CcSEcCtD
Clavulanate—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00268	0.00268	CcSEcCtD
Clavulanate—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.00267	0.00267	CcSEcCtD
Clavulanate—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00266	0.00266	CcSEcCtD
Clavulanate—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00265	0.00265	CcSEcCtD
Clavulanate—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00265	0.00265	CcSEcCtD
Clavulanate—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00264	0.00264	CcSEcCtD
Clavulanate—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00262	0.00262	CcSEcCtD
Clavulanate—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.00257	0.00257	CcSEcCtD
Clavulanate—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.00253	0.00253	CcSEcCtD
Clavulanate—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.0025	0.0025	CcSEcCtD
Clavulanate—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.00248	0.00248	CcSEcCtD
Clavulanate—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00246	0.00246	CcSEcCtD
Clavulanate—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00245	0.00245	CcSEcCtD
Clavulanate—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00245	0.00245	CcSEcCtD
Clavulanate—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.00238	0.00238	CcSEcCtD
Clavulanate—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00236	0.00236	CcSEcCtD
Clavulanate—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00236	0.00236	CcSEcCtD
Clavulanate—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00231	0.00231	CcSEcCtD
Clavulanate—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00227	0.00227	CcSEcCtD
Clavulanate—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00226	0.00226	CcSEcCtD
Clavulanate—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00225	0.00225	CcSEcCtD
Clavulanate—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00223	0.00223	CcSEcCtD
Clavulanate—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00212	0.00212	CcSEcCtD
